Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity
Eunok Lee, Kerrie J. Sandgren, Gabriel Duette, et al.
Journal of Virology (2020) Vol. 95, Iss. 6
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
Jerald Sadoff, Glenda Gray, An Vandebosch, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 23, pp. 2187-2201
Open Access | Times Cited: 2369
SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19
Alba Grifoni, John Sidney, Randi Vita, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1076-1092
Open Access | Times Cited: 292
The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection
Christina M. Arieta, Yushu Joy Xie, Daniel Rothenberg, et al.
Cell (2023) Vol. 186, Iss. 11, pp. 2392-2409.e21
Open Access | Times Cited: 58
Landscape of epitopes targeted by T cells in 852 individuals recovered from COVID-19: Meta-analysis, immunoprevalence, and web platform
Ahmed Abdul Quadeer, Syed Faraz Ahmed, Matthew R. McKay
Cell Reports Medicine (2021) Vol. 2, Iss. 6, pp. 100312-100312
Open Access | Times Cited: 60
Improved control of SARS-CoV-2 by treatment with a nucleocapsid-specific monoclonal antibody
Tanushree Dangi, Sarah Sanchez, Jacob Class, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 23
Open Access | Times Cited: 54
Prevalent and immunodominant CD8 T cell epitopes are conserved in SARS-CoV-2 variants
Saskia Meyer, Isaac Blaas, Ravi Chand Bollineni, et al.
Cell Reports (2023) Vol. 42, Iss. 1, pp. 111995-111995
Open Access | Times Cited: 26
SARS-CoV-2 nucleocapsid protein triggers hyperinflammation via protein-protein interaction-mediated intracellular Cl− accumulation in respiratory epithelium
Lei Chen, Wei‐jie Guan, Zhuo-Er Qiu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 30
Multiple COVID-19 vaccine doses in CLL and MBL improve immune responses with progressive and high seroconversion
Yandong Shen, Jane A. Freeman, Juliette Holland, et al.
Blood (2022) Vol. 140, Iss. 25, pp. 2709-2721
Open Access | Times Cited: 29
The role of SARS-CoV-2 N protein in diagnosis and vaccination in the context of emerging variants: present status and prospects
Wanchen Song, Zhongbiao Fang, Feike Ma, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 18
Molecular characterization of SARS-CoV-2 nucleocapsid protein
Yanping Huang, Junkai Chen, Siwei Chen, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 7
Comparing the Nucleocapsid Proteins of Human Coronaviruses: Structure, Immunoregulation, Vaccine, and Targeted Drug
Bo Zhang, Junjie Tian, Qintao Zhang, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 25
Protective HLA alleles against severe COVID-19: HLA-A*68 as an ancestral protection allele in Tapachula-Chiapas, Mexico
Susana Hernández-Doño, Roberto González, Ma Guadalupe Trujillo-Vizuet, et al.
Clinical Immunology (2022) Vol. 238, pp. 108990-108990
Open Access | Times Cited: 22
SARS‐CoV‐2 nucleocapsid: Biological functions and implication for disease diagnosis and vaccine design
Faezeh Maghsood, Ahmad Ghorbani, Hamidreza Yadegari, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 3
Closed Access | Times Cited: 14
Comprehensive Analysis of the Immune Response to SARS-CoV-2 Epitopes: Unveiling Potential Targets for Vaccine Development
Huixiong Deng, Yanlei Li, Gefei Wang, et al.
Biology (2025) Vol. 14, Iss. 1, pp. 67-67
Open Access
Perspective: diagnostic laboratories should urgently develop T cell assays for SARS-CoV-2 infection
Rohan Ameratunga, See-Tarn Woon, A. M. Jordan, et al.
Expert Review of Clinical Immunology (2021) Vol. 17, Iss. 5, pp. 421-430
Closed Access | Times Cited: 30
CD8+ T-cell immune escape by SARS-CoV-2 variants of concern
Arnaud John Kombe Kombe, Fleury Augustin Nsole Biteghe, Zélia Nelly Ndoutoume, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
A Review of Inactivated COVID-19 Vaccine Development in China: Focusing on Safety and Efficacy in Special Populations
Lidan Hu, Jingmiao Sun, Yan Wang, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1045-1045
Open Access | Times Cited: 12
Key Considerations for the Development of Safe and Effective SARS‐CoV‐2 Subunit Vaccine: A Peptide‐Based Vaccine Alternative
Ahmed O. Shalash, Waleed M. Hussein, Mariusz Skwarczyński, et al.
Advanced Science (2021) Vol. 8, Iss. 16
Open Access | Times Cited: 26
Protein engineering responses to the COVID-19 pandemic
Ching‐Lin Hsieh, Jason S. McLellan
Current Opinion in Structural Biology (2022) Vol. 74, pp. 102385-102385
Open Access | Times Cited: 18
Protection from COVID-19 with a VSV-based vaccine expressing the spike and nucleocapsid proteins
Kyle L. O’Donnell, Tylisha Gourdine, Paige Fletcher, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
Using residue interaction networks to understand protein function and evolution and to engineer new proteins
Dariia Yehorova, Bruno Di Geronimo, Michael Robinson, et al.
Current Opinion in Structural Biology (2024) Vol. 89, pp. 102922-102922
Open Access | Times Cited: 3
The conformational stability of pro-apoptotic BAX is dictated by discrete residues of the protein core
Noah B. Bloch, Thomas E. Wales, Michelle S. Prew, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 22
Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector
Irina Isakova–Sivak, Ekaterina Stepanova, Victoria Matyushenko, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 1142-1142
Open Access | Times Cited: 14
The HLA-II immunopeptidome of SARS-CoV-2
Shira Weingarten-Gabbay, Da‐Yuan Chen, Siranush Sarkizova, et al.
Cell Reports (2023) Vol. 43, Iss. 1, pp. 113596-113596
Open Access | Times Cited: 8
A systemic review of T-cell epitopes defined from the proteome of SARS-CoV-2
Xiaoxiao Jin, Xiaotao Liu, Chuanlai Shen
Virus Research (2022) Vol. 324, pp. 199024-199024
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top